Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human genetic and immunological determinants of critical COVID-19 pneumonia
Qian Zhang, Paul Bastard, Adem Karbuz, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 587-598
Open Access | Times Cited: 322

Showing 1-25 of 322 citing articles:

The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100663-100663
Open Access | Times Cited: 317
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Jérémy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 21
Open Access | Times Cited: 159
A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development
Thaíse Yasmine Vasconcelos de Lima Cavalcanti, Mylena Ribeiro Pereira, Sérgio Oliveira de Paula, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 969-969
Open Access | Times Cited: 151
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 122
COVID-19 2022 update: transition of the pandemic to the endemic phase
Michela Biancolella, Vito Luigi Colona, Ruty Mehrian‐Shai, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 119
The human genetic epidemiology of COVID-19
Mari Niemi, Mark J. Daly, Andrea Ganna
Nature Reviews Genetics (2022) Vol. 23, Iss. 9, pp. 533-546
Open Access | Times Cited: 118
Studying severe long COVID to understand post-infectious disorders beyond COVID-19
Petter Brodin, Giorgio Casari, Liam Townsend, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 879-882
Open Access | Times Cited: 117
From rare disorders of immunity to common determinants of infection: Following the mechanistic thread
Jean‐Laurent Casanova, Laurent Abel
Cell (2022) Vol. 185, Iss. 17, pp. 3086-3103
Open Access | Times Cited: 105
Human autoantibodies underlying infectious diseases
Anne Puel, Paul Bastard, Jacinta Bustamante, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 4
Open Access | Times Cited: 95
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
Qian Zhang, Daniela Matuozzo, Jérémie Le Pen, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 8
Open Access | Times Cited: 92
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID
Matthew C. Woodruff, Kevin S. Bonham, Fabliha A. Anam, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 85
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Qian Zhang, Andrés Pizzorno, Lisa Miorin, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 80
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 75
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 70
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria
Jérémie Rosain, Anna‐Lena Neehus, Jérémy Manry, et al.
Cell (2023) Vol. 186, Iss. 3, pp. 621-645.e33
Open Access | Times Cited: 65
Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
Sindhu Mohandas, Prasanna Jagannathan, Timothy J. Henrich, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 63
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients
Adrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 9
Open Access | Times Cited: 63
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Tom Le Voyer, Audrey V. Parent, Xian Liu, et al.
Nature (2023) Vol. 623, Iss. 7988, pp. 803-813
Open Access | Times Cited: 63
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection
Sunil K. Ahuja, Muthu Saravanan Manoharan, Grace C. Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 45
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Ann‐Kathrin Reuschl, Lucy Thorne, Matthew Whelan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 451-463
Open Access | Times Cited: 45
Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2
Manon Venet, Margarida Sá Ribeiro, Élodie Décembre, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Al Ozonoff, Naresh Doni Jayavelu, Shanshan Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 33
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top